Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Protalix BioTherapeutics- Inc. (PLX)

0.4421 0.009 (2.08%)

07-19 15:59

Open:

0.4399

Pre. Close:

0.4331

High:

0.47

Low:

0.4332

Volume:

293,323

Market Cap:

64M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.471 - 0.473

0.473 - 0.476

Low:

0.423 - 0.427

0.427 - 0.43

Close:

0.435 - 0.44

0.44 - 0.444

Technical analysis  (as of: 2018-07-19 4:32:04 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 0.56     One year: 0.65

Support:

Support1: 0.42    Support2: 0.38

Resistance:

Resistance1: 0.48    Resistance2: 0.56

Pivot:

0.44

Moving Averages:

MA(5): 0.44     MA(20): 0.44

MA(100): 0.48     MA(250): 0.58

MACD:

MACD(12,26):     Signal(12,26,9):

%K %D:

%K(14,3): 60.70     %D(3): 64.68

RSI:

RSI(14): 49.03

52-Week:

High: 0.92  Low: 0.38  Change(%): -40.3

Average Vol(K):

3-Month: 42297  10-Days 37851

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
PLX has closed below upper band by 42.0%. Bollinger Bands are 53.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to PLX's normal range. The bands have been in this narrow range for 21 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-06-27T18:47:46-04:00
Translate Bio prices upsized initial public offering

2018-06-19T13:47:50-04:00
Translate Bio Prepares For $100 Million U.S. IPO

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

145.57

Shares Float (M)

141.10

% Held by Insiders

3.10

% Held by Institutions

12.10

Shares Short (K)

2430

Shares Short Prior Month (K)

Stock Financials

EPS

-0.310

EPS Est. Current Year

-0.180

EPS Est. Next Year

-0.110

EPS Est. Next Quarter

-0.010

Forward EPS

0.190

Book Value (p.s.)

24.330

PEG Ratio

-0.09

Profit Margin

Operating Margin

-178.42

Return on Assets (ttm)

-52.0

Return on Equity (ttm)

65.8

Qtrly Rev. Growth

57.6

Gross Profit (p.s.)

0.016

Sales Per Share

EBITDA (p.s.)

-0.023

Qtrly Earnings Growth

Operating Cash Flow (M)

-10.98

Levered Free Cash Flow (M)

-26.48

atoplab.com

Valuation

P/E

-1.43

P/E Growth Ratio

0.03

P/BV

0.02

P/S

429043296.00

P/CF

-5.86

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.